Todd Davenport on The Impacts of Long COVID
Todd Davenport, Professor and Chair, Department of Physical Therapy, University of the Pacific, shared on LinkedIn:
”Our latest manuscript, “ME/CFS and Long COVID Demonstrate Similar Bioenergetic Impairment and Recovery Failure on Two‑Day Cardiopulmonary Exercise Testing,” is now posted as a preprint.
Using two‑day cardiopulmonary exercise testing (CPET), we compared physiologic responses in people living with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long COVID, and matched non‑disabled controls, stratifying our analysis by sex.
Here’s what we learned:
- Both ME/CFS and Long COVID show similar failure to recover after exertion
- Largest impairments occur at the ventilatory anaerobic threshold, suggesting similar aerobic system impairment
- Females exhibited more pronounced post‑exertional abnormalities than males
- No meaningful differences were observed between ME/CFS and Long COVID on two-day CPET, suggesting they share a bioenergetic pathophysiology
- Severe functional impairment was common in both patient groups and was not explained by effort preference, deconditioning, ventilation, or hemodynamics
These results reinforce post‑exertional malaise (PEM) is a measurable physiological phenomenon.
They underscore the value of two‑day CPET to:
– Differentiate PEM from normal recovery using objective measures
– Inform disability evaluations in people who can and choose to have a CPET
– Improve precision in rehabilitation and treatment trials
I’m grateful to my co‑authors and to the patients.
Their generous engagement continues to advance our understanding of these terribly disabling yet largely ignored chronic conditions.”
Read the full article here.
Article: ME/CFS and Long COVID Demonstrate Similar Bioenergetic Impairment and Recovery Failure on Two-Day Cardiopulmonary Exercise Testing
Authors: Todd Davenport, Staci Stevens, Jared Stevens, Mark Van Ness

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 14, 2026, 18:30Irina Gontschar: What the Epkinly FDA Review Teaches Us About Sponsor Oversight
-
Aug 14, 2026, 18:20Venkata Sagi: Systemic Anticoagulation or Left Atrial Appendage Closure?
-
Aug 14, 2026, 18:02Marios Psychogios: Every Minute Matters in Acute Stroke Care
-
Aug 14, 2026, 17:57Molly Lippold-Meinholz: The Magic of Camp for Kids With Bleeding Disorders
-
Aug 14, 2026, 17:52Will Thomas: Why Dose Every Missed Thromboprophylaxis Matter
-
Aug 14, 2026, 17:42Nandini Pethe: Representing MicroHealth at BDC
-
Aug 14, 2026, 17:30Richard Habis: Hemophilia Does Not Only Affect the Child
-
Aug 14, 2026, 17:00Zahra Safarzadeh: The Critical Role of the Laboratory in Hemophilia Care
-
Aug 14, 2026, 16:39Yuriy Prokopenko: Advancing Hemostasis Through Scientific Collaboration